The best quarterly since covid took the wind out of our sails - there is a lot to like in this:
- nice jump in cash receipts while US accounts and sales per account was a little down - are we seeing the positive impact of sales outside of the US now? Really important we see traction outside of the US.
- Price rise in place going forward - from the broker report released a couple of months ago, we seem to have a lot of room here with Coopervision being much more expensive from memory
- Cash use, taking out inventory build-up, is going down - excellent. Plus freight cost control in place going forward
- Like the decision to delay any CEO appointment - great to see the board is being careful with our cash, and we just need to grind out our strategy
- Fully randomised clinical trial underway - not much danger here given the effect size seen in the longitudinal study already out there.
- Re-affirmed cash is sufficient to reach approx. breakeven.
Would have liked some specifics on international sales, and an update on the toric lense, but overall very pleasing.
The best quarterly since covid took the wind out of our sails -...
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.020(14.3%) |
Mkt cap ! $8.806M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 17.0¢ | 15.0¢ | $57.03K | 360.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4500 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 6376 | 1 |
View Market Depth
| Last trade - 15.58pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
15.5¢ |
Change
0.020 ( 10.7 %) |
||||
| Open | High | Low | Volume | ||
| 15.5¢ | 15.5¢ | 15.5¢ | 2090 | ||
| Last updated 14.09pm 31/05/2024 ? | |||||
| VTI (ASX) Chart |